Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 2
2001 2
2002 2
2003 2
2004 3
2005 8
2006 9
2007 5
2008 3
2009 5
2010 3
2011 8
2012 10
2013 5
2014 6
2015 8
2016 11
2017 17
2018 10
2019 17
2020 14
2021 19
2022 11
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL; ANDROMEDA Trial Investigators. Kastritis E, et al. Among authors: mollee p. N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631. N Engl J Med. 2021. PMID: 34192431 Clinical Trial.
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, Gillmore JD, Herrera GA, Jaccard A, Jevremovic D, Kastritis E, Kukreti V, Kyle RA, Lachmann HJ, Larsen CP, Ludwig H, Markowitz GS, Merlini G, Mollee P, Picken MM, Rajkumar VS, Royal V, Sanders PW, Sethi S, Venner CP, Voorhees PM, Wechalekar AD, Weiss BM, Nasr SH. Leung N, et al. Among authors: mollee p. Nat Rev Nephrol. 2019 Jan;15(1):45-59. doi: 10.1038/s41581-018-0077-4. Nat Rev Nephrol. 2019. PMID: 30510265 Free PMC article.
How to diagnose amyloidosis.
Mollee P, Renaut P, Gottlieb D, Goodman H. Mollee P, et al. Intern Med J. 2014 Jan;44(1):7-17. doi: 10.1111/imj.12288. Intern Med J. 2014. PMID: 24024789 Review.
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.
Trappe RU, Dierickx D, Zimmermann H, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Reinke P, Verhoef G, Subklewe M, Hüttmann A, Tousseyn T, Salles G, Kliem V, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S. Trappe RU, et al. Among authors: mollee p. J Clin Oncol. 2017 Feb 10;35(5):536-543. doi: 10.1200/JCO.2016.69.3564. Epub 2016 Dec 19. J Clin Oncol. 2017. PMID: 27992268 Clinical Trial.
Current approaches to the diagnosis and management of amyloidosis.
Taylor MS, Sidiqi H, Hare J, Kwok F, Choi B, Lee D, Baumwol J, Carroll AS, Vucic S, Neely P, Korczyk D, Thomas L, Mollee P, Stewart GJ, Gibbs SDJ. Taylor MS, et al. Among authors: mollee p. Intern Med J. 2022 Dec;52(12):2046-2067. doi: 10.1111/imj.15974. Epub 2022 Dec 7. Intern Med J. 2022. PMID: 36478370 Review.
The treatment of paraprotein-related kidney disease.
Hutchison CA, Xiong F, Mollee P. Hutchison CA, et al. Among authors: mollee p. Curr Opin Nephrol Hypertens. 2017 Nov;26(6):477-483. doi: 10.1097/MNH.0000000000000369. Curr Opin Nephrol Hypertens. 2017. PMID: 28885307 Review.
Pomalidomide - Author Reply.
Scott AP, Mollee P. Scott AP, et al. Among authors: mollee p. Leuk Lymphoma. 2019 Apr;60(4):1105. doi: 10.1080/10428194.2018.1516884. Epub 2018 Oct 2. Leuk Lymphoma. 2019. PMID: 30277106 No abstract available.
Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia.
Cass SH, Tobin JWD, Seo YD, Gener-Ricos G, Keung EZ, Burton EM, Davies MA, McQuade JL, Lazar AJ, Mason R, Millward M, Sandhu S, Khoo C, Warburton L, Guerra V, Haydon A, Dearden H, Menzies AM, Carlino MS, Smith JL, Mollee P, Burgess M, Mapp S, Keane C, Atkinson V, Parikh SA, Markovic SN, Ding W, Call TG, Hampel PJ, Long GV, Wargo JA, Ferrajoli A. Cass SH, et al. Among authors: mollee p. Ann Oncol. 2023 Sep;34(9):796-805. doi: 10.1016/j.annonc.2023.06.007. Epub 2023 Jul 4. Ann Oncol. 2023. PMID: 37414216
The epidemiology of amyloidosis in Australia.
Wisniowski B, McLeod D, Adams R, Harvey Y, Armes J, Papadimos D, Brown I, McGuire L, Mollee P. Wisniowski B, et al. Among authors: mollee p. Amyloid. 2019;26(sup1):132-133. doi: 10.1080/13506129.2019.1582481. Amyloid. 2019. PMID: 31343339 No abstract available.
168 results